LTC4

Ltc4 is a lipid of Fatty Acyls (FA) class. Ltc4 is associated with abnormalities such as Asthma, Eosinophilia, Pulmonary Eosinophilia, Pneumonia and Cardiovascular Diseases. The involved functions are known as Signal, Gene Expression, Stimulus, Signal Transduction and Metabolic Inhibition. Ltc4 often locates in Plasma membrane, Cytoplasm, Back, Cytoplasmic and Tissue membrane. The associated genes with LTC4 are STIM1 gene, ABCC2 gene, CD9 gene, Mutant Proteins and Amino Acids, Aromatic. The related lipids are glycolithocholate.

Cross Reference

Introduction

To understand associated biological information of LTC4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTC4?

LTC4 is suspected in Pneumonia, Asthma, Pulmonary Eosinophilia, Eosinophilia, Cardiovascular Diseases, Disintegration and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTC4

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Gastritis D005756 27 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Osteosarcoma D012516 50 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Per page 10 20 50 100 | Total 75

PubChem Associated disorders and diseases

What pathways are associated with LTC4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTC4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTC4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTC4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTC4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTC4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTC4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTC4

Download all related citations
Per page 10 20 50 100 | Total 1173
Authors Title Published Journal PubMed Link
Akagi M et al. Anti-allergic effect of tea-leaf saponin (TLS) from tea leaves (Camellia sinensis var. sinensis). 1997 Biol. Pharm. Bull. pmid:9178940
Son JK et al. Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2005 Biol. Pharm. Bull. pmid:16327145
Skarzynski DJ et al. Roles of tumor necrosis factor-alpha of the estrous cycle in cattle: an in vivo study. 2003 Biol. Reprod. pmid:12904309
Guo T et al. Protective Effect of an Antibody against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic Response. 2016 Biomed Res Int pmid:27213155
Pönicke K and Förster W Influence of leukotriene C4 on aggregation and on malondialdehyde formation of human blood platelets. 1984 Biomed. Biochim. Acta pmid:6440558
Ducep JB et al. Synthesis of 5- and 6-fluoro derivatives of 5,8,14-eicosatrienoic and 5,8,11,14-eicosatetraenoic acids. Effects of fluorinated arachidonic acids on leukotriene C4 production by macrophages. 1994 Bioorg. Med. Chem. pmid:7922133
Shaari K et al. Bioassay-guided identification of an anti-inflammatory prenylated acylphloroglucinol from Melicope ptelefolia and molecular insights into its interaction with 5-lipoxygenase. 2011 Bioorg. Med. Chem. pmid:21958738
Venkatachalam TK et al. Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fc epsilon RI receptor mediated mast cell leukotriene release. 2003 Bioorg. Med. Chem. pmid:12614897
Ohemeng KA et al. Novel bishydroxamic acids as 5-lipoxygenase inhibitors. 1994 Bioorg. Med. Chem. pmid:7922131
Norman BH et al. Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). 2002 Bioorg. Med. Chem. Lett. pmid:11958985
Venkatachalam TK et al. Inhibition of mast cell leukotriene release by thiourea derivatives. 2003 Bioorg. Med. Chem. Lett. pmid:12565956
Norman BH et al. Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146. 1999 Bioorg. Med. Chem. Lett. pmid:10612603
Vidal A et al. Synthesis of 19-[(2-azido-5-iodo)-benzoyloxy]-LTA4 and enzymatic conversion to the LTC4 analogue. 2000 Bioorg. Med. Chem. Lett. pmid:10762049
Ishihara K et al. Inhibition of icosanoid production in MC/9 mouse mast cells by n-3 polyunsaturated fatty acids isolated from edible marine algae. 1998 Biosci. Biotechnol. Biochem. pmid:9720225
Ju HR et al. Systemic release of mucosal mast-cell protease in primed brown Norway rats after feeding with beta-lactoglobulin. 1995 Biosci. Biotechnol. Biochem. pmid:7787291
Oliveira SH et al. Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. 2002 Blood pmid:12453875
Tschopp CM et al. Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. 2006 Blood pmid:16794249
Gagari E et al. Differential release of mast cell interleukin-6 via c-kit. 1997 Blood pmid:9108382
Lärfars G et al. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes. 1999 Blood pmid:9949184
Dannull J et al. Leukotriene C4 induces migration of human monocyte-derived dendritic cells without loss of immunostimulatory function. 2012 Blood pmid:22323449
Pecaric-Petkovic T et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. 2009 Blood pmid:18955562
Patella V et al. The antineoplastic bryostatins affect human basophils and mast cells differently. 1995 Blood pmid:7532037
Ochensberger B et al. IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. 1995 Blood pmid:7492759
Sjölinder M et al. Aberrant expression of active leukotriene C(4) synthase in CD16(+) neutrophils from patients with chronic myeloid leukemia. 2000 Blood pmid:10666225
Feng C et al. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. 2006 Blood pmid:16357326
Ito Y et al. Guinea pig cysteinyl leukotriene receptor 2 (gpCysLT2) mediates cell proliferation and intracellular calcium mobilization by LTC4 and LTD4. 2008 BMB Rep pmid:18315950
Kirshenbaum AS et al. Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition. 2008 BMC Immunol. pmid:18687131
Russell RL et al. Arachidonic acid pathway alterations in cerebrospinal fluid of dogs with naturally occurring spinal cord injury. 2016 BMC Neurosci pmid:27287721
Linares Segovia B et al. Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city. 2014 BMC Pulm Med pmid:25000942
Fugazzola M et al. Non-genomic action of beclomethasone dipropionate on bronchoconstriction caused by leukotriene C4 in precision cut lung slices in the horse. 2012 BMC Vet. Res. pmid:22963524
Votta BJ and Bertolini DR Cytokine suppressive anti-inflammatory compounds inhibit bone resorption in vitro. 1994 Sep-Oct Bone pmid:7980964
Taichman RS et al. Human osteosarcomas inhibit hematopoietic colony formation: partial reversal by antibody to transforming growth factor-beta 1. 1997 Bone pmid:9315339
Patella V et al. Heterogeneous effects of protamine on human mast cells and basophils. 1997 Br J Anaesth pmid:9215027
Scadding GK et al. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge. 1994 Br J Clin Pharmacol pmid:7893587
Barnouin K et al. Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione. 1998 Br. J. Cancer pmid:9460989
Wehner J and Neuber K Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. 2001 Br. J. Dermatol. pmid:11531797
Stenke L et al. Novel enzymatic abnormalities in AML and CML in blast crisis: elevated leucocyte leukotriene C4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate. 1998 Br. J. Haematol. pmid:9674747
Tan Y and Lim LH trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation. 2008 Br. J. Pharmacol. pmid:18776917
Mackay GA and Stewart AG R2D(2) for C(4)Eo: an 'alliance' of PGD(2) receptors is required for LTC(4) production by human eosinophils. 2011 Br. J. Pharmacol. pmid:21426314
Zuany-Amorim C et al. Strain-dependency of leukotriene C4 generation from isolated lungs of immunized mice. 1994 Br. J. Pharmacol. pmid:7524994
Arumugam TV et al. Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist. 2003 Br. J. Pharmacol. pmid:12967936
Vicente AM et al. Modulation of haem oxygenase-1 expression by nitric oxide and leukotrienes in zymosan-activated macrophages. 2001 Br. J. Pharmacol. pmid:11454666
Hung ND et al. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. 2011 Br. J. Pharmacol. pmid:21091644
Bäck M et al. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea. 2001 Br. J. Pharmacol. pmid:11487525
Wunder F et al. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor. 2010 Br. J. Pharmacol. pmid:20423349
Held HD et al. Characterization of airway and vascular responses in murine lungs. 1999 Br. J. Pharmacol. pmid:10205008
Renes J et al. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1. 1999 Br. J. Pharmacol. pmid:10188979
Setoguchi H et al. Leukotriene C(4) enhances the contraction of porcine tracheal smooth muscle through the activation of Y-27632, a rho kinase inhibitor, sensitive pathway. 2001 Br. J. Pharmacol. pmid:11156567
Terlouw SA et al. Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells. 2001 Br. J. Pharmacol. pmid:11682439
Gutmann H et al. P-glycoprotein- and mrp2-mediated octreotide transport in renal proximal tubule. 2000 Br. J. Pharmacol. pmid:10694230